Advocacy in Action:
Funding Research. Improving Patient Lives.
There is nothing more powerful than your voice when it comes to influencing members of Congress. Federal funding for lifesaving cancer research is the key to unlocking breakthroughs to increase survival.
Although much still needs to be done, we have accomplished so much thanks to the determination of our advocates.
Our Advocacy Accomplishments
2011: We secured the inclusion of pancreatic cancer in the Department of Defense's (DoD) Peer-Reviewed Cancer Research Program, and retained pancreatic cancer in the program every year since – resulting in 40 pancreatic cancer research grants for a total of $15 million to date.
2012: We led the efforts for Congress to pass the Recalcitrant Cancer Research Act, which resulted in a greater focus on pancreatic cancer at the National Cancer Institute (NCI). This critical law required the NCI to develop and implement a national framework for advancing key research strategies to improve patient outcomes.
2014: In the first year that the Recalcitrant Cancer Research Act was implemented, NCI funding for pancreatic cancer increased by $20 million to $122 million.
2016: Congress passed the 21st Century Cures Act, which authorized Congress to create a new funding stream for the National Institutes of Health (NIH), specifically $4.8 billion in new funding for the NIH over the next 10 years – with $1.8 billion for the National Cancer Moonshot Initiative over the next seven years.
2017: Our advocacy efforts resulted in Congress increasing funding for the DoD's Peer Reviewed Cancer Research Program from $50 million to $60 million – a 20 percent increase from the prior year.
2017: For the second year in a row, we secured a $2 billion increase in funding for the NIH in FY17. After years of flat funding or decreases, Congress approved the first $2 billion increase for FY16.
Our Advocacy Grassroots Network Continues to Grow
In 2017, we celebrated the 10th anniversary of National Pancreatic Cancer Advocacy Day with more than 600 supporters including nearly 100 survivors, with representation from all 50 states. Capitol Hill turned purple and we took the national media by storm!
Our grassroots network has increased tenfold since 2007 and continues to grow year after year. This expansion ensures that every member of Congress will know funding for cancer research simply cannot wait.
To date, 110 members of the 115th Congress joined the Congressional Caucus on the Deadliest Cancers to show that they stand with us as we Demand Better. For Patients. For Survival.